The race to lead the World Health Organization (WHO) is intensifying. Early digital campaign data reveals an active contest to capture the pivotal African vote and outreach to established United States, European Union and corporate networks. While the full field of contenders is still taking shape ahead of the formal nomination deadline, digital engagement metrics […] Continue reading ->
A new modelling study suggests that US Medicare “Most-Favored-Nation” policies on drug prices would cut Medicare spending on brand-name drugs, but potentially incentivize companies to increase prices or delay new drug launches elsewhere. Efforts to control the cost of government spending on drugs culminated in a Most-Favored-Nation (MFN) policy, a Trump administration initiative which ties […] Continue reading ->
Country controversies, secret terms, opaque procurement, and massive unspent Congressional funds have characterised the first year of the America First Global Health Strategy.. “Services are weaker than they were a year ago, HIV testing is down, treatment of children living with HIV is down, and community-based prevention is gutted,” said Emily Bass, expert consultant for […] Continue reading ->
The lethality of the Ebola outbreak in the Democratic Republic of Congo (DRC) is not just in its genome. Neither is it entirely explained by the country’s internal instability and defunded, broken health infrastructure. Have we allowed the virus to outsmart us by overlooking past lessons? The signs around the DRC’s 17th Ebola outbreak indicate […] Continue reading ->
EU negotiator Americo Zampetti warns that ideological polarisation over pathogen access threatens to derail the WHO Pandemic Agreement. On the eve of the eighth round of talks on an annex to the Pandemic Agreement, the European Union’s (EU) chief negotiator has warned that “ideology” is blocking consensus. Negotiators meet at the Intergovernmental Working Group (IGWG) […] Continue reading ->